melatonin has been researched along with Bladder Cancer in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin has anticancer activity when administered alone or in combination with standard chemotherapeutic agents, with measurable improvements seen in the clinical endpoints of tumor regression and patient survival." | 5.72 | Melatonin Inhibits EMT in Bladder Cancer by Targeting Autophagy. ( Chao, CC; Chen, PC; Hsiao, SY; Lin, TH; Tang, CH, 2022) |
| "Melatonin treatment inhibited proliferation and migration and enhanced apoptosis of bladder cancer cells." | 5.62 | Melatonin reduces proliferation and promotes apoptosis of bladder cancer cells by suppressing O-GlcNAcylation of cyclin-dependent-like kinase 5. ( Gou, J; Guan, F; Jiang, Y; Li, H; Li, X; Liang, L; Lin, M; Ma, Q; Ning, L; Tan, Z; Wu, J, 2021) |
| "Melatonin is a well-known natural hormone, which shows a potential anticancer effect in many human cancers." | 1.91 | Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis. ( Deng, Z; Fang, Y; Ju, L; Liu, W; Qian, K; Shan, D; Shen, D; Wang, G; Wang, X; Xiao, Y; Yu, M; Zhang, Y; Zhou, F, 2023) |
| "The melatonin treatment significantly reduced T24 and UMUC3 bladder cancer cell proliferation and clonogenic ability." | 1.91 | Melatonin induces cell cycle arrest and suppresses tumor invasion in urinary bladder urothelial carcinoma. ( Chang, YC; Chen, SL; Dong, C; Hsieh, TY; Lee, TH; Lu, LY; Sung, WW; Yu, CY, 2023) |
| "Melatonin has anticancer activity when administered alone or in combination with standard chemotherapeutic agents, with measurable improvements seen in the clinical endpoints of tumor regression and patient survival." | 1.72 | Melatonin Inhibits EMT in Bladder Cancer by Targeting Autophagy. ( Chao, CC; Chen, PC; Hsiao, SY; Lin, TH; Tang, CH, 2022) |
| "Melatonin treatment inhibited proliferation and migration and enhanced apoptosis of bladder cancer cells." | 1.62 | Melatonin reduces proliferation and promotes apoptosis of bladder cancer cells by suppressing O-GlcNAcylation of cyclin-dependent-like kinase 5. ( Gou, J; Guan, F; Jiang, Y; Li, H; Li, X; Liang, L; Lin, M; Ma, Q; Ning, L; Tan, Z; Wu, J, 2021) |
| "Melatonin is a hormone secreted from pineal glands of mammals and possesses diverse physiological functions." | 1.46 | Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKβ/NF-κB/COX-2 signaling pathway. ( Du, X; Hou, Q; Jiang, J; Liu, F; Peng, Y; Shrestha, S; Song, J; Song, X; Sun, D; Sun, X; Wang, Q; Xing, J; Zhao, J; Zhu, J, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 6 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 1 |
| Tan, Z | 1 |
| Li, H | 1 |
| Lin, M | 1 |
| Jiang, Y | 1 |
| Liang, L | 1 |
| Ma, Q | 1 |
| Gou, J | 1 |
| Ning, L | 1 |
| Li, X | 2 |
| Guan, F | 1 |
| Miyake, M | 1 |
| Nishimura, N | 1 |
| Ohnishi, S | 1 |
| Oda, Y | 1 |
| Miyamoto, T | 1 |
| Shimizu, T | 1 |
| Hori, S | 1 |
| Morizawa, Y | 1 |
| Gotoh, D | 1 |
| Nakai, Y | 1 |
| Anai, S | 1 |
| Torimoto, K | 1 |
| Aoki, K | 1 |
| Fujii, T | 1 |
| Tanaka, N | 1 |
| Fujimoto, K | 1 |
| Hsiao, SY | 1 |
| Tang, CH | 1 |
| Chen, PC | 1 |
| Lin, TH | 1 |
| Chao, CC | 1 |
| Shen, D | 1 |
| Deng, Z | 1 |
| Liu, W | 1 |
| Zhou, F | 1 |
| Fang, Y | 1 |
| Shan, D | 1 |
| Wang, G | 1 |
| Qian, K | 1 |
| Yu, M | 1 |
| Zhang, Y | 2 |
| Ju, L | 1 |
| Xiao, Y | 1 |
| Wang, X | 1 |
| Hsieh, TY | 1 |
| Sung, WW | 1 |
| Chang, YC | 1 |
| Yu, CY | 1 |
| Lu, LY | 1 |
| Dong, C | 1 |
| Lee, TH | 1 |
| Chen, SL | 1 |
| Lim, MA | 1 |
| Pranata, R | 1 |
| Jabłońska, J | 1 |
| Kluska, M | 1 |
| Lin, XJ | 1 |
| Liu, R | 1 |
| Li, C | 1 |
| Yi, X | 1 |
| Fu, B | 1 |
| Walker, MJ | 1 |
| Xu, XM | 1 |
| Sun, G | 1 |
| Lin, CH | 1 |
| Lan, NSR | 1 |
| Yeap, BB | 1 |
| Fegan, PG | 1 |
| Green, G | 1 |
| Rankin, JM | 1 |
| Dwivedi, G | 1 |
| Habibi, A | 1 |
| Karami, S | 1 |
| Varmira, K | 1 |
| Hadadi, M | 1 |
| Zhang, M | 1 |
| Li, Q | 1 |
| Lan, X | 1 |
| Wang, Z | 1 |
| Zheng, J | 1 |
| Eskandari-Sedighi, G | 1 |
| Cortez, LM | 1 |
| Yang, J | 1 |
| Daude, N | 1 |
| Shmeit, K | 1 |
| Sim, V | 1 |
| Westaway, D | 1 |
| Weigand, S | 1 |
| O'Connor, M | 1 |
| Blažek, P | 1 |
| Kantenwein, V | 1 |
| Friedrich, L | 1 |
| Grebmer, C | 1 |
| Schaarschmidt, C | 1 |
| von Olshausen, G | 1 |
| Reents, T | 1 |
| Deisenhofer, I | 1 |
| Lennerz, C | 1 |
| Kolb, C | 1 |
| Iwata, H | 1 |
| Sassa, N | 1 |
| Kato, M | 1 |
| Murase, Y | 1 |
| Seko, S | 1 |
| Kawanishi, H | 1 |
| Hattori, R | 1 |
| Gotoh, M | 1 |
| Tsuzuki, T | 1 |
| Chen, D | 1 |
| Zhang, J | 1 |
| Chen, YP | 1 |
| Li, Y | 1 |
| Zhou, M | 1 |
| Waterhouse, GIN | 1 |
| Sun, J | 1 |
| Shi, W | 1 |
| Ai, S | 1 |
| Manne, ASN | 1 |
| Hegde, AR | 1 |
| Raut, SY | 1 |
| Rao, RR | 1 |
| Kulkarni, VI | 1 |
| Mutalik, S | 1 |
| Jafari, R | 1 |
| Hectors, SJ | 1 |
| Koehne de González, AK | 1 |
| Spincemaille, P | 1 |
| Prince, MR | 1 |
| Brittenham, GM | 1 |
| Wang, Y | 1 |
| Shrestha, S | 1 |
| Zhu, J | 1 |
| Wang, Q | 1 |
| Du, X | 1 |
| Liu, F | 1 |
| Jiang, J | 1 |
| Song, J | 1 |
| Xing, J | 1 |
| Sun, D | 1 |
| Hou, Q | 1 |
| Peng, Y | 1 |
| Zhao, J | 1 |
| Sun, X | 1 |
| Song, X | 1 |
| Han, YS | 1 |
| Kim, SM | 1 |
| Lee, JH | 1 |
| Jung, SK | 1 |
| Noh, H | 1 |
| Lee, SH | 1 |
| Chen, YT | 1 |
| Yang, CC | 1 |
| Shao, PL | 1 |
| Huang, CR | 1 |
| Yip, HK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Association of Anesthesia Technique With Morbidity and Mortality in Patients With COVID-19 and Surgery for Hip Fracture: a Retrospective Population Cohort Study[NCT05133648] | 1,000 participants (Anticipated) | Observational | 2023-01-05 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 other studies available for melatonin and Bladder Cancer
| Article | Year |
|---|---|
Melatonin reduces proliferation and promotes apoptosis of bladder cancer cells by suppressing O-GlcNAcylation of cyclin-dependent-like kinase 5.
Topics: Apoptosis; Cell Proliferation; Cyclins; Humans; Melatonin; N-Acetylglucosaminyltransferases; Proteom | 2021 |
Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer.
Topics: Administration, Intravesical; BCG Vaccine; Creatinine; Humans; Male; Melatonin; Neoplasm Invasivenes | 2022 |
Melatonin Inhibits EMT in Bladder Cancer by Targeting Autophagy.
Topics: Animals; Autophagy; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Melatonin; Mice; Signal Tra | 2022 |
Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis.
Topics: Biomarkers, Tumor; Cell Transformation, Neoplastic; DNA-Binding Proteins; Glycolysis; Humans; Melato | 2023 |
Melatonin induces cell cycle arrest and suppresses tumor invasion in urinary bladder urothelial carcinoma.
Topics: Apoptosis; Carcinoma, Transitional Cell; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell | 2023 |
Topics: Acute Coronary Syndrome; Adolescent; Adsorption; Adult; Aged; Animals; Aspergillus; Aspergillus oryz | 2021 |
Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKβ/NF-κB/COX-2 signaling pathway.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Checkpoints; Cell Line, Tumor; C | 2017 |
Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrP
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Survival; Cellular Senescence; Humans; Immunohist | 2019 |
Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway.
Topics: Animals; Male; Matrix Metalloproteinase 9; Melatonin; Mice; Mice, Inbred C57BL; Proto-Oncogene Prote | 2019 |